In humans, AD is an heterogenous condition, which in the relatively few hereditary familial cases derives from key mutations within the amyloid precursor protein (APP) and presenilin 1–2 (PSEN 1–2) genes, and from the resulting increased presence of Aβ deposition and aggregates of hyperphosphorylated tau protein. This evidence concerns the gene PSEN1 and Alzheimer disease.